ð ç¬ç« ç ç©¶è«æ â 2026.06.02
泚ç®è«æ 3ä»¶
1. ð¥ ç£å»åŠã»æ é€åŠ
ç¬ãšç«ã®ãæç¶çè 代æ¿çæ³ïŒCRRTïŒãã®äœ¿ãæ¹ãåœéè èèå³ã°ã«ãŒãïŒIRISïŒãåã®åæã¬ã€ãã©ã€ã³ã«ââéæã®é©å¿ã»ã«ããŒãã«ã»æååºã»çµäºã¿ã€ãã³ã°ã暪æçã«æŽçïŒJVIM 2026幎2æïŒ
ð 2026.02.10
åœéè èèå³ã°ã«ãŒãïŒIRISïŒãç¬ãšç«ã®ããã®ãæç¶çè 代æ¿çæ³ïŒCRRTïŒContinuous Renal Replacement TherapyïŒãã«é¢ããåã®ãã¹ããã©ã¯ãã£ã¹ã»ã³ã³ã»ã³ãµã¹ã¬ã€ãã©ã€ã³ãçºè¡šããJournal of Veterinary Internal MedicineïŒJVIMïŒ2026幎2æå·ã«æ²èŒãããæ¥æ§è é害ïŒAKIïŒãè¬å€æ§è äžå šãæè¡çæ§ã·ã§ãã¯ãªã©ã§è æ©èœãçæéã«èããäœäžããç¬ç«ã«å¯Ÿãããã€éæãéå§ãã©ãç¶ãããã®å€æåºæºããŸãšããŠãããå ·äœçã«ã¯ãé©å¿çïŒé«ã«ãªãŠã è¡çã茞液äžå¿æ§ãå°¿æ¯çæ§è³çãªã©ïŒã®åªå é äœããã«ã¬ãŒãåããã«ã«ãŒã¡ã³ã«ããŒãã«ã®ç眮äœçœ®ãã¯ãšã³é žæååºvså šèº«ãããªã³åã®éžã³æ¹ã茞液é床ã®ç®æšå€ãçµäºæ¡ä»¶ãŸã§ç¶²çŸ ã
ãããŸã§CRRTã¯å€§åŠç é¢ãäžéšã®é«åºŠ2次æœèšã«éå®ãããŠããããã¬ã€ãã©ã€ã³ã®æ®åã§ãå€éã察å¿ã§ããæåœã®éžæè¢ããšããŠåºããå¯èœæ§ããããæ¥æ¬ã§ãæ±äº¬å€§ã»åæµ·é倧ã»JARMeCãªã©äž»èŠãªåç©å»çã»ã³ã¿ãŒãCRRTãå°å ¥ããŠãããä»åŸã¯å°åã®2æ¬¡èšºçæœèšã§ãæšæºåãæåŸ ããããCRRTã¯è²»çšè² æ ã倧ããïŒ10ã30äžåè¶ ïŒæ¥ïŒããããããä¿éºé©çšç¯å²ãšæ²»çè²»ã®èŠç©ãããæ©ãã«ç£å»åž«ãšçžè«ããããšãéèŠã
ð J Vet Intern Med, 2026幎2æ
ð https://pubmed.ncbi.nlm.nih.gov/41513167/
ð¥ ç£å»åŠã»æ é€åŠ
2. ð¥ ç£å»åŠã»æ é€åŠ
ãç¬ãã«ããŠã€ã«ã¹ææçã«æ»äº¡ç0%ãââã·ã§ã«ã¿ãŒç¬ã®èªç¶ææã§ãCPMAïŒç¬ãã«ããŠã€ã«ã¹ã»ã¢ãã¯ããŒãã«æäœïŒã®èšåºå¹æãåããŠæ€èšŒïŒUniv of Illinois 2026幎4æïŒ
ð 2026.04.08
ã€ãªãã€å€§åŠç£å»åŠéšã®ãã ã»ã»ã«ãã£ã³ã°ç£å»ç é¢é·ãããCPMAïŒCanine Parvovirus Monoclonal AntibodyïŒã®èªç¶ææäžã§ã®èšåºå¹æããã·ã§ã«ã¿ãŒç¬ã察象ã«ç³»çµ±çã«è©äŸ¡ããå ±åãçºè¡šãããCPMAã¯ç¬ãã«ããŠã€ã«ã¹2åã«ç¹ç°çã«çµåããŠãŠã€ã«ã¹ã®çްèå äŸµå ¥ã黿¢ããåæã¢ãã¯ããŒãã«æäœã§ãElanco瀟ãããCanine Parvovirus Monoclonal Antibodyãã®åç§°ã§USDAæ¡ä»¶ä»ãæ¿èªãååŸæžã¿ãå®éšçæ»æã¢ãã«ïŒ21é ïŒã§ã¯æ²»ççŸ€ã®æ»äº¡ç0%ïŒãã©ã»ã矀57%ïŒãšåçãªå·®ã瀺ãããŠããããã·ã§ã«ã¿ãŒã§ã®èªç¶ææã±ãŒã¹ã§ãååã»å æ°æ¶å€±ã»é£æ¬²äœäžã®è§£æ¶ãææã«æ©ãŸã£ãããšã远å ã§ç€ºãããã
ãã«ããŠã€ã«ã¹ã¯çåŸ2ã6ã«æã®åç¬ã§èŽæ»ç10ã90%ã«éããåºè¡æ§äžç¢ã»ååã»æè¡çã§çæéã«äº¡ããªãããšãããããããŸã§æ²»çã¯èŒžæ¶²ã»å¶åå€ã»æçå€ãªã©å¯Ÿççæ³ã«éãããŠãããæ ¹æ¬æ²»çã¯ãªãã£ããCPMAã¯1åéèæ³šå°ã§ãç¬ç é¢ã§ã®è²»çšã¯1é ããã600ã1,200ãã«ïŒæ¥æ¬ã§ã¯æªæ¿èªã»å°æ¥Elancoæ¥æ¬æ³äººçµç±ã§å°å ¥ã®å¯èœæ§ïŒãCPMAã§ãé©åãªã¯ã¯ãã³æ¥çš®ãäžæ¬¡äºé²ã®äž»åœ¹ã§ããããšã«å€ããã¯ãªããåç¬ã®ã³ã¢ã¯ã¯ãã³ïŒDHPPïŒã¹ã±ãžã¥ãŒã«ïŒ6ã»9ã»12é±éœ¢ïŒã¯ç¢ºå®ã«å®ãããšã倧åã
ð University of Illinois Veterinary Medicine, 2026幎4æ
ð https://vetmed.illinois.edu/2026/04/08/canine-parvovirus-monoclonal-antibody/
ð¥ ç£å»åŠã»æ é€åŠ
3. ð§ è¡åã»èªç¥ç§åŠ
ãç¬ã¯äººéãèŠãããšã»èŠãŠããªãããšãåºå¥ã§ãããïŒãââ22é ã®3ã«ããéžæèª²é¡ã§âä»è ã®èŠçæšå®âãæ€èšŒãç«¶äºçžæãå ã«éžãã æã®ã¿ãèªåããèŠãŠããªãã«ããããåªå ïŒAnimal Cognition 2025幎ïŒ
ð 2025.09.15
ãã³ã¬ãªãŒã®Eötvös Loránd倧åŠãªã©ã®ããŒã ãããããç¬22é ã察象ã«ãããã®ã³ã³ããã£ã¿ãŒãéå»ã«äœãèŠãããç¬ãæšå®ã§ããããã3ã«ããéžæèª²é¡ã§æ€èšŒããAnimal CognitionèªïŒSpringer NatureïŒã«çºè¡šããã3ã€ã®ã«ããã®ãã¡2ã€ã«ãªã€ããé ãæé ãç¬ã«èгå¯ãããããã®ã³ã³ããã£ã¿ãŒã«ã¯1ã€ããé ãç¬éãèŠããªãã£ãããã®åŸãç¬ãšãããé çªã«ã«ãããéžã¶ãé£ç©ç«¶äºãã§ãç¬ãã©ã®ã«ãããéžã¶ããèšé²ããã
çµæãç¬ã¯ãäž¡æ¹ãšãèŠãã«ããããšãèªåããèŠãŠããªãã«ããããã©ã³ãã ã«éžãã ãããããå ã«éžã¶æã«éã£ãŠãèªåããèŠãŠããªãã«ããããããåªå ããåŸåã瀺ãããããã¯ããããç¥ããªãã«ãããåªå ããããšãã”theory of mind”ïŒå¿ã®çè«ïŒçãªåŸåã匱ã瀺åãããã確å®ãªçµ±èšçå·®ã¯åŸãããªãã£ããèè ãã¯ãç¬ã¯ããã®æ³šæã»èŠç·ã«ã¯ææã ãããããéå»ã«äœãèŠãããšãããç¥èåž°å±ããŸã§ã¯ç¢ºå®ã«è¿œè·¡ã§ããŠãããšã¯èšããªãããšçµè«ãå ±åæ³šæïŒé廿°æ¥ã®ç ç©¶ïŒãšã¯å¥ã®èªç¥ã¿ã¹ã¯ã§ãç¬ã®ç€ŸäŒèªç¥ã®äžéã瀺åããéèŠãªç¥èŠãå®¶åºç¬ã®èªç¥åãé倧è©äŸ¡ããããèŠããŠããªããã°åãããªããããšãåæã«åŠç¿ãããèŠç¹ã圹ç«ã¡ããã ã
ð Animal Cognition, 2025幎
ð https://link.springer.com/article/10.1007/s10071-025-02034-0
ð§ è¡åã»èªç¥ç§åŠ
æ¯æ7æé ä¿¡

ã³ã¡ã³ããæ®ã